All terms in UPHENO

Label Id Description
oxazolidines CHEBI_38329
intestinal cholesterol absorption GO_0030299 [Uptake of cholesterol into the blood by absorption from the small intestine.]
intestinal lipid absorption GO_0098856 [Any process in which lipids are taken up from the contents of the intestine.]
cholesterol transport GO_0030301 [The directed movement of cholesterol, cholest-5-en-3-beta-ol, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.]
imidazolidinone CHEBI_55370 [An imidazolidine containing one or more oxo groups.]
imidazolidines CHEBI_38261
isoxazoles CHEBI_55373 [Oxazoles in which the N and O atoms are adjacent.]
oxazole CHEBI_35790 [An azole based on a five-membered heterocyclic aromatic skeleton containing one N and one O atom.]
basihyal cartilage hypoplastic, abnormal ZP_0010600 [Abnormal(ly) hypoplastic (of) basihyal cartilage.]
pharyngeal arch cartilage hypoplastic, abnormal ZP_0000816 [Abnormal(ly) hypoplastic (of) pharyngeal arch cartilage.]
basihyal cartilage decreased size, abnormal ZP_0001985 [Abnormal(ly) decreased size (of) basihyal cartilage.]
corneal epithelium disorganized, abnormal ZP_0010601 [Abnormal(ly) disorganized (of) corneal epithelium.]
disorganized corneal epithelium UPHENO_0084697 [Disorganization of corneal epithelium.]
corneal epithelium morphology, abnormal ZP_0000440 [Abnormal(ly) morphology (of) corneal epithelium.]
epithelium disorganized, abnormal ZP_0015204 [Abnormal(ly) disorganized (of) epithelium.]
ocular blood vessel has extra parts of type hyaloid vessel, abnormal ZP_0010606 [Abnormal(ly) has extra parts of type (of) ocular blood vessel (hyaloid vessel).]
ocular blood vessel morphology, abnormal ZP_0009555 [Abnormal(ly) morphology (of) ocular blood vessel.]
cranial vasculature has extra parts of type blood vessel, abnormal ZP_0016756 [Abnormal(ly) has extra parts of type (of) cranial vasculature (blood vessel).]
bone mineralization GO_0030282 [The deposition of hydroxyapatite, a form of calcium phosphate with the formula Ca10(PO4)6(OH)2, in bone tissue.]
biomineral tissue development GO_0031214 [Formation of hard tissues that consist mainly of inorganic compounds, and also contain a small amounts of organic matrices that are believed to play important roles in their formation.]